News
China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension: Shanghai, China Tuesday, April 22, 2025, 18:00 Hrs [IST] Ro ...
Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering RNA (siRNA) drug ...
Akka Nasan ibsetti waggaa wagggaan wantoonni caccabaa dhagaa fakkaatan hawaa keessaa gara pilaaneetii keenya Dacheetti ni ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback